Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › TNGX
FARALLON CAPITAL MANAGEMENT, L.L.C. position in TNGX
TANGO THERAPEUTICS INC · Health Care
FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 12,277,000 shares of TNGX (TANGO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$383.8M, representing 1.78% of its reported portfolio and ranking #18 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TNGX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How FARALLON CAPITAL MANAGEMENT, L.L.C.'s TNGX position evolved
FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in TNGX in Q4 2024 at 4,000,000 shares (US$12.4M). The position peaked in Q2 2026 at 12,277,000 shares, worth US$383.8M. Across 7 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 12,277,000 shares valued at US$383.8M — an increase of 3,179,589 shares quarter over quarter.. Notable position changes include a 99% increase in Q2 2025 (shares rose 64% over the following quarter), a 30% trim in Q1 2026 (shares rose 49% over the following quarter), a 35% increase in Q2 2026 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 4.00M | $12.36M | New |
| Q1 2025 | 4.61M | $6.32M | Add |
| Q2 2025 | 9.16M | $46.88M | Add |
| Q3 2025 | 10.76M | $90.36M | Add |
| Q4 2025 | 13.06M | $115.72M | Add |
| Q1 2026 | 9.10M | $190.32M | Reduce |
| Q2 2026 | 12.28M | $383.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 85 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), Boxer Capital Management, LLC (US$340.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- RTW INVESTMENTS, LP 13.90M sh · $434.53M · Q2 2026
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- Boxer Capital Management, LLC 10.88M sh · $339.99M · Q2 2026
- TCG Crossover Management, LLC 9.08M sh · $283.88M · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $198.74M · Q2 2026
- Siren, L.L.C. 6.18M sh · $193.17M · Q2 2026
- Deep Track Capital, LP 4.20M sh · $131.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- Woodline Partners LP 4.00M sh · $125.06M · Q2 2026
- TRV GP IV, LLC 6.37M sh · $120.18M · Q2 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M sh · $95.66M · Q2 2026
More on FARALLON CAPITAL MANAGEMENT, L.L.C.
FAQ
How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held TNGX?
FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TNGX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in TNGX?
As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 12.28M shares of TNGX (TANGO THERAPEUTICS INC), valued at $383.78M, representing 1.78% of its reported portfolio and ranking #18.
Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling TNGX?
In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in TNGX. The position peaked in Q2 2026 at 12.28M shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, Boxer Capital Management, LLC, among 85 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.